Name: Formulating and Characterizing an Exosome-based Dopamine Carrier System (Video) | JoVE Journal
Uploaded: 2022-04-04T14:00:00.000+00:00
Duration: 6 min 8 s
Description: Learn to formulate dopamine-loaded exosomes from Wharton's jelly mesenchymal stem cells for targeted drug delivery. This protocol covers isolation, characterization, loading, and cytotoxicity assessment.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The work was primarily supported by research funding provided by Y&#305;ld&#305;z Technical University Scientific Research Projects (TSA-2021-4713).

NOTE: See the Table of Materials for details related to all materials and equipment used in this protocol.
1. Culturing and cryopreservation of Wharton's jelly mesenchymal stem cells
<ol>
	<li>Remove the WJ-MSCs (from ATCC) from the -80 °C freezer. Seed the cells into a flask containing DMEM-F12 medium supplemented with 10% fetal bovine serum (FBS). Incubate them at 37 °C in an incubator containing 5% CO2.</li>
	<li>Change the culture medium every 2 days. Passage the cells when they reach 80% confluence. Wash the cells to be passaged with 5 mL of phosphate-buffered saline (PBS). 
	NOTE: Washing with PBS before adding trypsin ensures easy separation of cells from the flask surface.</li>
	<li>Remove the PBS and add 5 mL of trypsin-EDTA solution to the flask. Incubate the flask for 5 min at 37 °C in an incubator containing 5% CO2.</li>
	<li>Collect the supernatant into the tube and centrifuge at 1,500 x g for 5 min. After centrifugation, remove the supernatant and add 1 mL of DMEM-F12 + 10% FBS to the tube by pipetting.</li>
	<li>Transfer the cells to a larger flask and continue the culture by adding DMEM-F12 + 10% FBS until sufficient exosomes are obtained35. 
	NOTE: Cultured cells are frozen at a density of 1 million/mL with 10% dimethyl sulfoxide (DMSO) and stored at -80 °C.</li>
</ol>
2. Production of exosomes from Wharton's Jelly mesenchymal stem cells
NOTE: Exosomes are isolated from cultured WJ-MSCs. Exosome isolation is performed when cells cover the flask surface and reach approximately 80% density.
<ol>
	<li>Remove the supernatant medium containing 10% FBS from the flask and wash the cells with 5 mL of PBS. Add serum-free DMEM-F12 medium to the cells after rinsing with PBS. Incubate flasks for 48 h at 37 °C in a 5% CO2 incubator. Following incubation, collect the serum-free medium in the tube and store at -20 °C. 
	NOTE: In step 2.1, 180 mL of serum-free medium is collected and stored at -20 °C. After thawing, a batch centrifugation process is started, as described below.</li>
	<li>Isolation of exosomes
	<ol>
		<li>Centrifuge the collected serum-free medium at 300 x g for 10 min at +4 °C. Carefully withdraw the supernatant and transfer it to another tube.</li>
		<li>Centrifuge the collected supernatant at 2,000 × g for 10 min at +4 °C. Carefully withdraw the supernatant and transfer it to another tube.</li>
		<li>Centrifuge the collected supernatant at 10,000 × g for 30 min at +4 °C. Carefully withdraw the supernatant and transfer it to another tube.</li>
		<li>Transfer the collected supernatant to ultracentrifuge tubes and ultracentrifuge at 110,000 × g for 130 min. Slowly remove the supernatant and add 1 mL of PBS to the pellet.</li>
		<li>Vortex the pellet and ultracentrifuge at 110,000 × g for 70 min at +4 °C36​ (Figure 1). Slowly remove the supernatant and add 1 mL of PBS to the pellet. 
		NOTE: After the ultracentrifugation steps are completed, the exosomes obtained can be stored at -80 °C. The obtained pellet is now ready for characterization.</li>
	</ol>
	</li>
</ol>
<img alt="Wharton jelly stem cells isolation process diagram; cell culture, centrifugation, CO₂ incubation." class="xfigimg" src="/files/ftp_upload/63624/63624fig01.jpg" data-altupdatedat="1788282455000" data-alt="Figure 1"> 
Figure 1: Exosome isolation. <a href="https://www.jove.com/files/ftp_upload/63624/63624fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
3. Characterization of exosomes
<ol>
	<li>Nanoparticle Tracking Analysis (NTA) 
	NOTE: Nanoparticle tracking analysis is performed to determine the size and concentration of the isolated exosomes. Tablets used for 1x PBS solution must be in the range of pH 7.3-7.5. 1x PBS Solution contains 10 mM phosphate buffer, 137 mM sodium chloride, and 2.7 mM potassium chloride. The solution is prepared by adding 1 PBS tablet in 100 mL of distilled water. This prepared solution is sterilized by autoclaving.
	<ol>
		<li>Dilute the exosomes 100-fold by adding 990 µL of PBS to 10 µL of exosomes. Take the diluted suspension into a disposable syringe.</li>
		<li>Turn on the NTA device and connect the computer. Open the software.</li>
		<li>Inject the sample in the syringe into the tubing in the cassette section of the device. Close the cassette cover of the device.</li>
		<li>In the software that opens, click on the Start Analysis button. Save the results obtained by pressing the Record button.</li>
	</ol>
	</li>
	<li>Dynamic light scattering analysis 
	NOTE: Exosomes isolated for zeta potential and size measurement are also diluted in the same manner as for NTA analysis.
	<ol>
		<li>Add 980 µL of PBS to 20 µL of the exosomes.</li>
		<li>Open the zeta sizing device and the connected computer. Open the software.</li>
		<li>Add the suspension from step 3.2.1 to the disposable cuvette. Open the lid of the device, place the cuvette in the cassette, and close the lid.</li>
		<li>Select the cuvette type in the device's software. Click on the Start Analysis button for zeta potential and dimensional analysis. 
		NOTE: Analyses are performed separately for dimensional analysis and zeta potential.</li>
	</ol>
	</li>
</ol>
4. Dopamine loading into exosomes
NOTE: After the characterization of WJ-MSCs exosomes is completed, dopamine-loaded exosomes were obtained as a drug delivery system. Drug loading into exosomes is performed using the incubation method.
<ol>
	<li>Add 3 mL of PBS to the exosome suspension from step 2.2.5. Sterilize the diluted suspension by filtration using 0.22 µm filters. Transfer 500 µL of the sterilized exosome suspension to another tube.</li>
	<li>Prepare dopamine solution (0.5 mg/mL) with distilled water. Add 500 µL of dopamine solution into the tubes containing the exosomes.</li>
	<li>Add saponin to the suspension in step 4.2. Incubate the prepared exosome-dopamine suspension for 24 h at 37 °C. 
	NOTE: Saponin concentration should not exceed 0.002% of the total solution.</li>
	<li>Ultracentrifuge the suspension at 90,000 × g for 70 min to remove free dopamine and saponin from the medium. Store the isolated exosomes at -20 °C until use for further analysis37. 
	NOTE: Add 0.02% ascorbic acid for the stability of the prepared dopamine solution.</li>
</ol>
5. Characterization of dopamine loaded exosomes
<ol>
	<li>Nanoparticle tracking analysis (NTA) 
	NOTE: Nanoparticle tracking analysis is performed to determine the size and concentration of isolated exosomes.
	<ol>
		<li>Follow steps 3.1.1-3.1.4 to dilute the exosomes and perform NTA.</li>
	</ol>
	</li>
	<li>Dynamic light scattering analysis 
	NOTE: Exosomes isolated for zeta potential and size measurement are also diluted similarly to NTA analysis.
	<ol>
		<li>Follow steps 3.2.1-3.2.4 to dilute the exosomes and perform dynamic light scattering analysis. 
		NOTE: Size and zeta potentials for each solution (saponin, dopamine, exosome-dopamine) are analyzed separately.</li>
	</ol>
	</li>
</ol>
6. High-Performance Liquid Chromatography (HPLC)
NOTE: The amounts of dopamine loaded into exosomes are measured by the high-performance liquid chromatography (HPLC) method. To detect the presence of dopamine within the obtained formulation, exosomes are detonated by a special process.
<ol>
	<li>Put the formulation in a 75 °C heater to evaporate. Add acetonitrile (50:50 ratio) to the suspension and vortex. Sonicate the solution for 10 min.</li>
	<li>Centrifuge the solution for 10 min at 10,000 × g. Filter the supernatant through a 0.22 µm filter.</li>
	<li>Analyze all analytes using a C18 column at 30 °C at a flow rate of 1 mL/min (the mobile phase H2O/acetonitrile). Measure the absorbance at 230 nm38.</li>
</ol>
7. Drug loading capacity (DL) measurement and in vitro drug release kinetics
<ol>
	<li>Drug loading capacity (DL) 
	NOTE: The amount of dopamine loaded into exosomes is quantified using UV-Vis spectroscopy. The absorbance is read at 280 nm. The collected supernatants during synthesis are used to measure the amount of unloaded drug. The dopamine concentration in the supernatant is determined via a standard calibration curve for dopamine.
	<ol>
		<li>Prepare a stock solution of 1 mg/mL of dopamine. Prepare concentrations of 0.05, 0.1, 0.2, 0.3, 0.4, and 0.5 mg/mL from the stock solution using distilled water. 
		NOTE: Add 0.02% ascorbic acid for the stability of the prepared dopamine solution.</li>
		<li>Generate a standard calibration curve by measuring the absorbance of each dilution of dopamine at 280 nm in a UV-Spectrophotometer.</li>
		<li>Measure the absorbance of the supernatant at 280 nm.</li>
		<li>Calculate the drug loading capacity for dopamine using Eq (1)39. 
		DL (%) = <img alt="Protein binding calculation, formula: (A(Total)-A(Supernatant))/A(Total), percentage yield." src="/files/ftp_upload/63624/63624eq01.jpg" style="margin: auto;" data-altupdatedat="1788282455000" data-alt="Equation 1"> 100 (1) 
		NOTE: The analysis is performed in triplicate.</li>
	</ol>
	</li>
	<li>In vitro drug release kinetics 
	NOTE: Drug release kinetics of dopamine-loaded exosomes are performed using a dialysis membrane. PBS, pH 7.4, is used as the release medium to simulate a physiological microenvironment.
	<ol>
		<li>Add 1 mL of dopamine-loaded exosomes to the dialysis membrane. Place the membrane in a beaker. Add 15 mL of PBS to the beaker.</li>
		<li>Sample 1 mL of release medium in a beaker at 0.5, 1, 2, 4, 6, and 8 h. At each time point, replace the volume of the sample with fresh PBS. Analyze the samples taken at specified intervals at 280 nm using a UV-Vis spectrometer.</li>
		<li>Calculate the results using Eq (2)40. 
		Release (%) = <img alt="Dopamine release ratio formula, Σ symbol; chemical equation for neurotransmitter analysis." src="/files/ftp_upload/63624/63624eq02.jpg" style="margin: auto;" data-altupdatedat="1788282455000" data-alt="Equation 2">  100  (2) 
		NOTE: A calibration curve is prepared for the determination of in vitro drug release kinetics. Dopamine solution is prepared at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, and 5.0 mg/mL concentrations. The UV absorbance value of each concentration is determined at 280 nm with a UV-Vis spectrophotometer.</li>
	</ol>
	</li>
</ol>
8. In vitro cytotoxicity test
<ol>
	<li>Revitalization and culture of fibroblasts
	<ol>
		<li>Remove the fibroblasts from the -80 °C freezer. Seed the cells into a flask containing DMEM-F12 + 10% FBS.</li>
		<li>Incubate the cells at 37 °C in an incubator containing 5% CO2. Change the culture medium every 2 days.</li>
		<li>Passage the cells until they reach 80% confluence. Follow steps 1.3-1.5. After centrifugation at 1,500 × g for 5 min, remove the supernatant, add 1 mL of DMEM-F12 + 10% FBS, and seed 10,000 cells per well in a 96 well plate.
		<ol>
			<li>Add DMEM-F12 medium + 10% FBS and incubate the cells at 37 °C for 18 h in an incubator containing 5% CO2. Change the medium of the wells at the end of the incubation.</li>
		</ol>
		</li>
		<li>Prepare the stock of dopamine-loaded exosome suspension. Dilute the dopamine-loaded exosome formulation with medium to obtain concentrations of 100 µL/mL, 250 µL/mL, 500 µL/mL, and 1,000 µL/mL.</li>
		<li>Add the prepared concentrations onto the cells within each well of the 96-well plate. Incubate the plates at 37 °C for 18 h in an incubator containing 5% CO241.</li>
	</ol>
	</li>
	<li>MTT cell viability assay 
	NOTE: At the end of the incubation, the viability ratios of cells are determined by the MTT test.
	<ol>
		<li>Prepare the MTT solution (5 mg/mL) with PBS. Add 10 µL of MTT solution to each well. Incubate for 4 h at 37 °C.</li>
		<li>At the end of the incubation, add 100 µL of DMSO to each well. Incubate the plates for 30 min at room temperature in the dark. Measure the absorbance values in ELISA reader at 570 nm42,43. 
		NOTE: The MTT viability test is performed in triplicate.</li>
	</ol>
	</li>
</ol>

The authors declare that they have no competing financial interests.

Exosomes are small membrane vesicles with dimensions of 40-200 nm secreted by most cell types, e.g., MSCs1. Capable of enabling communication between cells, exosomes can enter cells in different ways such as endocytosis, phagocytosis, micropinocytosis, lipid-mediated internalization, and fusion33,44. Compared to other nanocarrier systems, the lipids and cholesterol found on the exosome surface confer the ability to carry both hydrophilic a...

Exosomes, bioactive vesicles with significant features, range in size from 40 nm to 200 nm. Exosomes originate from the cell membrane and are formed because of the release of the endosomes1. These structures serve as cell-to-cell communicators and interact with neighboring cells to facilitate the transfer of active molecules. Exosomes can be isolated from many different sources. These include body fluids such as plasma, urine, cerebrospinal fluid, saliva, as well as cell lines cultured under in vitro conditions. Exosomes have an important role in the elimination of nerve damage, thanks to the biomacromolecules they contain, such as lipids, proteins, and nucleic acids2. Glia, which are the supporting cells of the nervous system3, transfer proteins and micro RNAs to the axons of neurons via exosomes4.
Lipids forming the myelin sheath, which are a characteristic feature in nerve conduction, are also released from oligodendrocytes via exosomes4,5. Exosomes are also involved in processes such as synaptic plasticity, neuronal stress response, cell-cell communication, and neurogenesis in the brain6,7. The fact that exosomes possess nano-dimensions enables them to pass through the BBB. There is a special transition route from the interstitial fluid to the cerebrospinal fluid after penetrating this membrane8. Thanks to their surface properties, exosomes can interact efficiently with target cells as a drug delivery system and actively deliver the loaded drugs.
Due to the expression of various adhesive proteins (tetraspanins and integrins) on the surface of exosomes, these extracellular vesicles can easily interact and fuse with host cell membranes9. It is thought that exosomes can be used as a drug delivery system, especially in the treatment of central nervous system diseases due to their ability to penetrate the BBB and their surface properties. Mesenchymal stem cell (MSC)-derived exosomes have a lower risk of immune rejection compared to allogeneic cellular therapies, and in this respect, they can be an important component of cell-free treatment applications10.
Dopamine is a molecule whose deficiency in the brain is the characteristic feature of Parkinson&#39;s disease (PD), worsening day by day11,12,13. It is known that PD is associated with degeneration of dopaminergic neurons in the substantia nigra of the mesencephalon and loss of motor neuron functions14,15. The death of dopaminergic neurons prevents the supply of the neurotransmitter dopamine to the brain striatum. This, in turn, results in the emergence of PD-specific symptoms16. These symptoms of PD are bradykinesia, postural instability, rigidity, and especially resting tremor12,13. Although PD was first described more than two centuries ago, studies to understand the pathology and etiology of the disease are still ongoing and it is currently accepted that PD is a complex systemic disease17. It is predicted that dopamine deficiency occurs, and clinical PD symptoms are observed when more than 80% of neurons degenerate18. In the treatment of the disease, incomplete dopamine supplementation is preferred to reduce motor symptoms. In vivo studies have shown that direct infusion of dopamine into the brain significantly reduces symptoms in animals19. Dopamine precursors such as L-DOPA (L-3,4-dihydroxyphenylalanine) and dopamine receptor drugs are used in the clinic because the direct infusion of dopamine into the brain is not possible in humans and dopamine entering the system cannot cross the BBB20. These types of drugs lose their effectiveness over time. However, there is still no curative treatment approach for PD. Hence, there is a huge necessity to develop new therapeutic strategies and treatment modalities to reveal the pathophysiology of the disease and reduce the impact of PD on patients.
Exosome-based studies have recently attracted attention for gathering information about both therapeutic approaches and pathologies of nervous system diseases. MSC-derived exosomes have been shown to reduce inflammation in nerve damage and contribute to neuronal regeneration21,22,23. In addition, it has been reported that MSC-derived exosome secretomes reduce apoptosis by showing neurotrophic and neuroprotective effects, especially on dopaminergic neurons24,25. Research on platforms in which exosomes are used as therapeutic drug delivery systems have intensively accelerated in recent years. In numerous studies, it has been observed that relevant drugs can be easily encapsulated into exosomes and delivered safely into target cells, tissues, and organs26,27. Different methods such as incubation, freeze/thaw cycles, sonication, and extrusion could be used for drug loading into exosomes28.
Coincubation with exosomes or exosome-like vesicles allows lipophilic small molecules to be passively encapsulated into these delivery systems28,29,30. In particular, various molecules such as curcumin31, catalase30, doxorubicin32, and paclitaxel33&#160;were effectively loaded into exosomes. It has been observed that catalase-containing exosomes, which have antioxidant activity, efficiently accumulated in the neurons and microglial cells in the brain and exhibited strong neuroprotective activities30. In the same study, saponin, added into the complex to increase the loading efficiency, was found to increase the drug loading percentage during incubation30,34. However, further studies are needed to establish the standards for drug loading into exosomes.
This paper describes the development of a nanocarrier system by encapsulation of dopamine into exosomes that were isolated from WJ-MSCs. All steps, including the cultivation of WJ-MSCs,&#160;isolation, and characterization of exosomes, drug loading experiments, characterization of dopamine-loaded exosomes with various techniques, and in vitro cytotoxicity analysis are explained in detail.

<table><tbody><tr><td>0.22 &amp;micro;m membrane filter</td><td>Aisimo</td><td></td><td>Used for the sterilization process</td></tr><tr><td>0.45 &amp;micro;m syringe filter</td><td>Aisimo</td><td></td><td>Used for the sterilization process</td></tr><tr><td>15 mL Falcon tube</td><td>Nest</td><td></td><td>Used in cell culture step</td></tr><tr><td>25 cm&lt;sup&gt;2&lt;/sup&gt; cell culture flasks (Falcon, TPP tissue culture flasks</td><td>Nest</td><td></td><td>Used in cell culture step</td></tr><tr><td>50 mL Falcon tube</td><td>Nest</td><td></td><td>Used in cell culture step</td></tr><tr><td>75 cm&lt;sup&gt;2&lt;/sup&gt; cell culture flasks (Falcon, TPP tissue culture flasks</td><td>Nest</td><td></td><td>Used in cell culture step</td></tr><tr><td>96 well plates (Falcon, TPP microplates)</td><td>Merck Millipore</td><td></td><td>Used in cell culture step</td></tr><tr><td>Acetonitrile</td><td>Sigma</td><td>271004-1L</td><td>Used for HPLC analysis</td></tr><tr><td>Autoclave</td><td>NUVE-OT 90L</td><td></td><td>Used for the sterilization process</td></tr><tr><td>Cell Culture Cabin</td><td>Hera Safe KS</td><td></td><td>Used for the cell culture process</td></tr><tr><td>Centrifugal</td><td>Hitachi</td><td>CF16RN</td><td>Used in the exosome isolation step</td></tr><tr><td>CO&lt;sub&gt;2&lt;/sub&gt; incubator with Safe Cell UV</td><td>Panasonic</td><td></td><td>Used for the cell culture process</td></tr><tr><td>Dopamine hydrochloride H8502-10G</td><td>Sigma</td><td>H8502-10G</td><td>Used in exosome dopamine loading</td></tr><tr><td>Dulbecco&#039;s Modified Eagle&#039;s Medium/Nutrient Mixture-F12</td><td>Sigma</td><td>RNBJ7249</td><td>Used as cell culture medium</td></tr><tr><td>Fetal Bovine Serum-FBS</td><td>Capricorn</td><td>FBS-16A</td><td>It was used by adding to the cell culture medium.</td></tr><tr><td>Freezer -80 &amp;deg;C</td><td>Panasonic</td><td>MDF-U5386S-PE</td><td>To store cells and the resulting exosomes</td></tr><tr><td>Fridge</td><td>Panasonic</td><td>MPR-215-PE</td><td>Used to store cell culture and other materials</td></tr><tr><td>High performance liquid chromatography-HPLC</td><td>Agilent Technologies</td><td></td><td>The presence of dopamine from the content of the obtained formulation was investigated.</td></tr><tr><td>Microscope- Primovert</td><td>Zeiss</td><td></td><td>Used to observe cells in cell culture.</td></tr><tr><td>MTT Assay</td><td>Biomatik</td><td></td><td>Used to measure cell viability</td></tr><tr><td>NanoSight NS300</td><td>Malvern panalytical</td><td>Malvern panalytical</td><td>Used for exosome characterization</td></tr><tr><td>Optima XPN-100 Ultracentrifuge</td><td>Beckman Coulter</td><td></td><td>Used in the exosome isolation step</td></tr><tr><td>PBS tablet</td><td>Biomatik</td><td>43602</td><td>In the preparation of the PBS solution</td></tr><tr><td>Penicilin/Streptomycin Solution</td><td>Capricorn</td><td>PB-S</td><td>It was added to the medium to prevent contamination in cell culture.</td></tr><tr><td>Pipette Aid</td><td>Isolab</td><td></td><td></td></tr><tr><td>Precision balance-Kern</td><td>Kern-ABJ220-4NM</td><td></td><td>Used in the preparation of solutions</td></tr><tr><td>Q500 Sonicator</td><td>Qsonica, LLC</td><td></td><td>Used to digest exosomes in HPLC analysis</td></tr><tr><td>Saponin</td><td>Sigma</td><td>47036-50G-F</td><td>It was used by adding it to the total solution in the exosome dopamine loading process.</td></tr><tr><td>Spectrostar-Nano-Spectrophotometry</td><td>BMG LABTECH</td><td></td><td>Used for MTT and drug release analyzes</td></tr><tr><td>SPSS 22</td><td></td><td></td><td>statistical package program</td></tr><tr><td>Vorteks-FinePCR</td><td>FinePCR-FineVortex</td><td></td><td>Used to mix solutions homogeneously</td></tr><tr><td>Water Bath 37 &amp;deg;C-Senova</td><td>Senova</td><td></td><td>Used in cell culture step</td></tr><tr><td>Wharton&amp;rsquo;s jelly mesenchymal stem cells</td><td>ATCC</td><td></td><td></td></tr><tr><td>ZetaSizer</td><td>Malvern Nano ZS</td><td>Malvern Nano ZS</td><td>Used for exosome characterization</td></tr></tbody></table>

formulating and characterizing an exosome-based dopamine carrier system

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Exosomes between 40 and 200 nm in size constitute the smallest subgroup of extracellular vesicles. These bioactive vesicles secreted by cells play an active role in intercellular cargo and communication. Exosomes are mostly found in body fluids such as plasma, cerebrospinal fluid, urine, saliva, amniotic fluid, colostrum, breast milk, joint fluid, semen, and pleural acid. Considering the size of exosomes, it is thought that they may play an important role in central nervous system diseases because they can pass through the blood-brain barrier (BBB). Hence, this study aimed to develop an exosome-based nanocarrier system by encapsulating dopamine into exosomes isolated from Wharton's jelly mesenchymal stem cells (WJ-MSCs). Exosomes that passed the characterization process were incubated with dopamine. The dopamine-loaded exosomes were recharacterized at the end of incubation. Dopamine-loaded exosomes were investigated in drug release and cytotoxicity assays. The results showed that dopamine could be successfully encapsulated within the exosomes and that the dopamine-loaded exosomes did not affect fibroblast viability.

Exosome isolation and characterization 
Wharton jelly stem cells are cultured and incubated in a serum-free medium for 48 h when the culture reaches sufficient density. After the end of the incubation, the supernatant is stored at -20 °C. The collected supernatants are diluted with PBS and subjected to ultracentrifugation (Figure 1). The obtained solution is analyzed by NTA and DLS analyses. The exosomes are sterilized by passing through a 0.22 µm filter. The average size...

Here, we aimed to obtain a formulation by dopamine loading of the isolated exosomes of stem cells from Wharton's jelly mesenchymal stem cells. Exosome isolation and characterization, drug loading into the resulting exosomes, and the cytotoxic activity of the developed formulation are described in this protocol.

Exosomes between 40 and 200 nm in size constitute the smallest subgroup of extracellular vesicles. These bioactive vesicles secreted by cells play an ...

formulating-characterizing-an-exosome-based-dopamine-carrier

Research

JoVE Journal

Bioengineering

The amperometric technique measures dopamine release from a single cell by detecting the oxidative current produced by spontaneous dopamine oxidization. Simultaneous voltage clamp and amperometry methodology reveal the mechanistic relationship between the overall "activity" of dopamine transporter and the regulatory role of this activity on the reverse transport of dopamine.

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Source: Yavuz, B., et al. Formulating and Characterizing an Exosome-based Dopamine Carrier System. J. Vis. Exp. (2022)This video demonstrates the formulation of dopamine-loaded exosomes, focusing on saponin-induced membrane permeabilization to enhance dopamine encapsulation within exosomes.

Formulating a Dopamine-Loaded Exosome Carrier System 

The goal of this protocol is to describe the preparation and characterization of physically entrapped, poorly water soluble drugs in micellar drug delivery systems composed of amphiphilic block copolymers.

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

A protocol for the preparation and characterization of lipophilic doxorubicin pro-drug loaded 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (DSPE-PEG) micelles is described.

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

A liquid crystal nanoparticle (LCNP) nanocarrier is exploited as a vehicle for the controlled delivery of a hydrophobic cargo to the plasma membrane of living cells.

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

This article describes the encapsulation of falcarindiol in lipid-coated 74 nm nanoparticles. The cellular uptake of the nanoparticles by human stem cells into lipid droplets is monitored by fluorescent and confocal imaging. Nanoparticles are fabricated by the rapid injection method of solvent shifting, and their size is measured with the dynamic light scattering technique.

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Here, we describe a magnetic separation-assisted high-speed homogenization method for large-scale production of endosome-derived nanovesicles as a new type of exosome mimics (EMs) that share the same biological origin and similar structure, morphology, and protein composition of native extracellular vesicles (EVs).

A Magnetic Separation-Assisted High-Speed Homogenization Method for Large-Scale Production of Endosome-Derived Vesicles

Exosomes possess significant clinical potential, but their practical application is limited due to easy in vivo clearance and poor stability. Microneedles present a solution by enabling localized delivery by puncturing physiological barriers and dry-state preservation, thereby addressing the limitations of exosome administration and expanding their clinical utility.

Fabrication and Characterization of Microneedle Patches for Loading and Delivery of Exosomes

The therapeutic application of extracellular vesicles (EVs) has the potential to revolutionize cancer treatment and drug delivery. Chimeric antigen receptor (CAR) cell-derived EVs (CAR-EVs) isolated using ion-exchange chromatography exhibit increased cargo capacity, significantly enhancing their functional efficacy. This study further characterizes CAR-EVs to elucidate their biological activity and therapeutic potential.

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Biofilms have complex interactions with their surrounding environment. To comprehensively investigate biofilm-environment interactions, we present here a series of methods to create heterogeneous chemical environment for biofilm development, to quantify local flow velocity, and to analyze mass transport in and around biofilm colonies.

Methods for Characterizing the Co-development of Biofilm and Habitat Heterogeneity

Learn to formulate dopamine-loaded exosomes from Wharton's jelly mesenchymal stem cells for targeted drug delivery. This protocol covers isolation, characterization, loading, and cytotoxicity assessment.

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Explore More Videos